• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
D,L-1’-Acetoxychavicol acetate

D,L-1’-Acetoxychavicol acetate

Product ID A0817
Cas No. 52946-22-2, 53890-21-4
Purity ≥98%
Product Unit SizeCostQuantityStock
25 mg $105.00 In stock
100 mg $388.40 In stock
250 mg $709.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

1’-Acetoxychavicol acetate (ACA) was originally found in Alpinia galanga; it exhibits anti-obesity, immunomodulatory, anti-inflammatory, anti-asthma, anti-allergic, antibiotic, antiviral, anti-parasitic, anti-angiogenic, anti-metastatic, anticancer chemotherapeutic, and chemopreventive activities. ACA activates transient receptor potential A1 (TRPA1) channels and inhibits xanthine oxidase. ACA inhibits proliferation of Staphylococcus and Leishmania and suppresses replication of the influenza virus by inhibiting CRM1. In animal models fed high-fat diets, ACA limits activity of glucose-6-phosphate dehydrogenase, suppresses lipid accumulation, increases activation of AMPK, and decreases fat mass and body weight. In animal models of OVA-induced asthma, ACA suppresses eosinophil infiltration, decreases levels of IgE, IL-4, IL-13, IL-12α, and IFN-γ, and prevents airway remodeling. In vitro, this compound increases levels of glutathione-S-transferase, NQO1, glutathione, Nrf2, and p21. Additionally, ACA inhibits VEGF-induced cellular proliferation, migration, adhesion, and tube formation in various in vitro and in vivo models. ACA also decreases NF-κB activation and invasiveness in cellular models. In vivo, this compound prevents skin tumor carcinogenesis. In cellular and animal models of oral squamous cell carcinoma, ACA inhibits cellular proliferation and decreases tumor volume. In glioblastoma cells, this compound decreases levels of IL-6 and IL-1α, inhibits cellular proliferation and migration, and induces apoptosis.

Product Info

Cas No.

52946-22-2, 53890-21-4

Purity

≥98%

Formula

C13H14O4

Formula Wt.

234.25

Chemical Name

D,L-1’-Acetoxychavicol acetate

IUPAC Name

[4-(1-acetyloxyprop-2-enyl)phenyl] acetate

Synonym

4-(Acetyloxy)-alpha-ethenylbenzenemethanol, CCRIS 7708; 1′-R,S-Acetoxychavicol Acetate; 1’-R,S-ACA. Galangal acetate, (RS)-; Galangal acetate, (+/-)-

Solubility

Soluble in DMSO (20 mg/mL), ethanol (20 mg/mL), DMF (14 mg/mL).

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

A0817 MSDS PDF

Info Sheet

A0817 Info Sheet PDF

References

Williams M, Tietzel I, Quick QA. 1'-Acetoxychavicol acetate promotes caspase 3-activated glioblastoma cell death by overcoming enhanced cytokine expression. Oncol Lett. 2013 Jun;5(6):1968-1972. PMID: 23833677.

Seo JW, Cho SC, Park SJ, et al. 1'-Acetoxychavicol acetate isolated from Alpinia galanga ameliorates ovalbumin-induced asthma in mice. PLoS One. 2013;8(2):e56447. PMID: 23451048.

Aziz AN, Ibrahim H, Rosmy Syamsir D, et al. Antimicrobial compounds from Alpinia conchigera. J Ethnopharmacol. 2013 Feb 13;145(3):798-802. PMID: 23266278.

Ohnishi R, Matsui-Yuasa I, Deguchi Y, et al. 1'-acetoxychavicol acetate inhibits adipogenesis in 3T3-L1 adipocytes and in high fat-fed rats. Am J Chin Med. 2012;40(6):1189-204. PMID: 23227791.

In LL, Arshad NM, Ibrahim H, et al. 1'-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations. BMC Complement Altern Med. 2012 Oct 9;12:179. PMID: 23043547.

Batra V, Syed Z, Gill JN, et al. Effects of the tropical ginger compound,1'-acetoxychavicol acetate, against tumor promotion in K5.Stat3C transgenic mice. J Exp Clin Cancer Res. 2012 Jun 15;31:57. PMID: 22704648.

Yaku K, Matsui-Yuasa I, Azuma H, et al. 1'-Acetoxychavicol acetate enhances the phase II enzyme activities via the increase in intranuclear Nrf2 level and cytosolic p21 level. Am J Chin Med. 2011;39(4):789-802. PMID: 21721157.

Pang X, Zhang L, Lai L, et al. 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway. Carcinogenesis. 2011 Jun;32(6):904-12. PMID: 21427164.

Watanabe K, Takatsuki H, Sonoda M, et al. Anti-influenza viral effects of novel nuclear export inhibitors from Valerianae Radix and Alpinia galanga. Drug Discov Ther. 2011 Feb;5(1):26-31. PMID: 22466093.

Kaur A, Singh R, Dey CS, et al. Antileishmanial phenylpropanoids from Alpinia galanga (Linn.) Willd. Indian J Exp Biol. 2010 Mar;48(3):314-7. PMID: 21046987.

Narukawa M, Koizumi K, Iwasaki Y, et al. Galangal pungent component, 1'-acetoxychavicol acetate, activates TRPA1. Biosci Biotechnol Biochem. 2010;74(8):1694-6. PMID: 20699565.

Ichikawa H, Takada Y, Murakami A, et al. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products. J Immunol. 2005 Jun 1;174(11):7383-92. PMID: 15905586.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B030962

    BAY-1251152

    Inhibitor of PTEFb/CDK9.

    ≥98%
  • C294458

    Chlorzoxazone

    Centrally acting muscle relaxant.

    ≥99%
  • I7478

    Istradefylline

    Adenosine A2A antagonist.

    ≥99%
  • C0172

    Carbimazole

    Methimazole prodrug; thyroid peroxidase inhibit...

    ≥98%
  • G4634

    Glipizide

    Sulfonylurea; ATP-sensitive K+ channel blocker....

    ≥98%
  • R183731

    Resiquimod

    Toll-like receptor 7/8 agonist

    ≥98%
  • F4857

    FMRF Amide

    Cardiostimulatory neuropeptide; delayed rectifi...

    ≥95%
  • C5618

    Coelenterazine, natural

    Light-emitting luciferin analog found in aquati...

    ≥98%
  • N5778

    Notoginsenoside R1

    Triterpene saponin found in species of Panax.

    ≥98%
  • G1745

    Gemcitabine Hydrochloride

    Nucleoside (deoxycytidine) analog; ribonucleoti...

    ≥98%
  • R0243

    Raloxifene Hydrochloride

    SERM.

    ≥98%
  • H9816

    2-Hydroxyestradiol

    Estradiol metabolite.

    ≥99%
  • I5354

    Iniparib

    Cysteine adduct inducer, PARP-1 inhibitor.

    ≥98%
  • A0978

    Actinonin

    Peptide deformylase, MMP meprin A, aminopeptida...

    ≥98%
  • G3558

    20R-Ginsenoside Rh2

    Triterpene saponin found in Panax.

    ≥98%
  • P7718

    Pterostilbene

    Stilbene, resveratrol analog.

    ≥98%
  • L1628

    Ac-LEHD-pNa

    Caspase 9 substrate.

    ≥95%
  • J023736

    (±)-Jasmonic Acid

    Phytohormone

    ≥98% (sum of isomers)
  • C9612

    Cyclosporin C

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%
  • M400005

    MK-5108 Hydrochloride

    Aurora kinase A inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only